
|**FOREVER TOMMYS TRUST**||**1203041**||
|---|---|---|---|
|**Receipts andpayments accounts**|||**CC16a**|
|01/04/2024<br>**For the period**<br>**from**|**To**|31/03/2025||



## **Section A Receipts and payments** 

|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest**<br>**£**<br>**1,214**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**1,214**<br>**-**<br>**-**<br>**-**<br>**1,214**<br>**3,122**<br>**760**<br>**-**<br>**298**<br>**-**<br>**-**<br>**186**<br>**500**<br>**-**<br> **4,866**<br>**-**<br>**-**<br> **-**<br>**4,866**<br>**-                 3,652**<br>**-**<br>**-**<br>**-                 3,652**|**Restricted**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Total funds**<br>**to the nearest £**<br>**1,214**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**1,214**<br>**-**<br>**-**<br>**-**<br>**1,214**<br>**3,122**<br>**760**<br>**-**<br>**298**<br>**-**<br>**-**<br>**186**<br>**500**<br>**-**<br>**4,866**<br>**-**<br>**-**<br>**-**<br>**4,866**<br>**-                 3,652**|**Total funds**<br>**to the nearest £**<br>**1,214**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**1,214**<br>**-**<br>**-**<br>**-**<br>**1,214**<br>**3,122**<br>**760**<br>**-**<br>**298**<br>**-**<br>**-**<br>**186**<br>**500**<br>**-**<br>**4,866**<br>**-**<br>**-**<br>**-**<br>**4,866**<br>**-                 3,652**|**Last year**<br>**to the nearest £**|
|---|---|---|---|---|---|---|
|Donations|**1,214**|||||**14,655**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
|**_Sub total_**_(Gross income for_<br>_AR)_|**1,214**|||||**14,655**|
||||||||
|**A2 Asset and investment sales,**<br>**(see table).**|||||||
||**-**||||||
||**-**|||||**-**|
|**_Sub total_**|**-**|||||**-**|
|**_Total receipts_**<br>**A3 Payments**|||||||
|||||||**14,655**|
||||||||
|Donations- Defibrillator|**3,122**|||||**7,017**|
|Event costs|**760**|||||**1,537**|
|Stationery& Printing|**-**|||||**27**|
|Advertising|**298**|||||**150**|
|Insurance|**-**|||||**101**|
|Other expenses|**-**|||||**190**|
|Donations-AED|**186**|||||**-**|
|Accountancyfee|**500**|||||**-**|
||**-**|||||**-**|
|**_Sub total_ **|**4,866**|||||**9,022**|
||||||||
|**A4 Asset and investment**<br>**purchases, (see table)**|||||||
||**-**||||||
||**-**||||||
|**_Sub total_ **|**-**|||||**-**|
|**_Total payments_**<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**|||||||
|||||||**9,022**|
||||||||
||**-                 3,652**|**-**|**-**|**-                 3,652**||**5,633**|
||**-**|**-**|**-**|**-**||**-**|
||**-**|**-**|**-**|**-**||**-**|
||**-                 3,652**|**-**|**-**|**-                 3,652**||**5,633**|



CCXX R1 accounts (SS) 

24/02/2026 

1 



## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>Signed by one or two trustees on<br>behalf of all the trustees<br>**B1 Cash funds**<br>**B2 Other monetary assets**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>**B5 Liabilities**<br>**B3 Investment assets**|Signature<br>**Details**<br>**Details**<br>Bank balance at at 31/03/2025<br>**Details**<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))<br>**Details**|**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**7,951**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**7,951**<br>**-**<br>Agreement Error<br>OK<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>James Astle|**Endowment**<br>**funds**<br>**to nearest £**|
|---|---|---|---|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**Endowment**<br>**funds**<br>**to nearest £**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
|||James Astle|2/25/2026|
|||||



CCXX R2 accounts (SS) 

24/02/2026 

2 

